Tag: blindness

Panel recommends Luxturna FDA approval for rare form of blindness

pharmanewsdaily- October 15, 2017

Luxturna FDA approval news : Luxturna (voretigene neparvovec), a gene therapy from Spark Therapeutics is closing in towards an FDA approval for treating blindness due ... Read More